GlassScriptPhysician profile
Faith Farris
NPI 1124865100
$1,181.37
in general payments reported to CMS, 2019-2025
14 companies · $914 in 2025
The $914 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $267 · 2025: $914.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,086 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,086.38 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $193.67 | 2024-2025 | Dupixent |
| Leo Pharma INC. | $137.09 | 2024-2025 | Adbry, Anzupgo |
| Incyte Corporation | $128.67 | 2025 | Opzelura |
| Abbvie INC. | $122.54 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $112.66 | 2024-2025 | Sotyktu |
| Janssen Biotech, INC. | $111.03 | 2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $85.95 | 2025 | |
| Ucb, INC. | $84.64 | 2024-2025 | Bimzelx |
| Lilly USA, LLC | $61.01 | 2025 | Ebglyss, Taltz |
| Pfizer INC. | $38.05 | 2024-2025 | |
| Genzyme Corporation | $37.67 | 2025 | |
| Sun Pharmaceutical Industries INC. | $27.82 | 2024 | |
| Galderma Laboratories, L.P. | $20.81 | 2025 | Nemluvio |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $19.76 | 2025 | Cabtreo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Faith Farris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.